Your browser doesn't support javascript.
loading
Epigenetic Treatment of Neurodegenerative Ophthalmic Disorders: An Eye Toward the Future.
Moos, Walter H; Faller, Douglas V; Glavas, Ioannis P; Harpp, David N; Irwin, Michael H; Kanara, Iphigenia; Pinkert, Carl A; Powers, Whitney R; Steliou, Kosta; Vavvas, Demetrios G; Kodukula, Krishna.
Afiliação
  • Moos WH; Department of Pharmaceutical Chemistry, School of Pharmacy, University of California San Francisco, San Francisco, California.
  • Faller DV; ShangPharma Innovation, Inc., South San Francisco, California.
  • Glavas IP; Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
  • Harpp DN; Cancer Research Center, Boston University School of Medicine, Boston, Massachusetts.
  • Irwin MH; Department of Ophthalmology, New York University School of Medicine, New York, New York.
  • Kanara I; Department of Chemistry, McGill University, Montreal, QC, Canada.
  • Pinkert CA; Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, Alabama.
  • Powers WR; Embassy of Greece in Moscow, Moscow, Russia.
  • Steliou K; Department of Biological Sciences, College of Arts and Sciences, The University of Alabama, Tuscaloosa, Alabama.
  • Vavvas DG; Department of Health Sciences, Boston University, Boston, Massachusetts.
  • Kodukula K; Department of Anatomy, Boston University School of Medicine, Boston, Massachusetts.
Biores Open Access ; 6(1): 169-181, 2017.
Article em En | MEDLINE | ID: mdl-29291141

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article